Page last updated: 2024-10-29

indole-3-carbinol and Libman-Sacks Disease

indole-3-carbinol has been researched along with Libman-Sacks Disease in 4 studies

indole-3-carbinol: occurs in edible cruciferous vegetables
indole-3-methanol : An indolyl alcohol carrying a hydroxymethyl group at position 3. It is a constituent of the cruciferous vegetables and had anticancer activity.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Eghbalpour, F1
Aghaei, M1
Ebrahimi, M1
Tahsili, MR1
Golalipour, M1
Mohammadi, S2
Yazdani, Y2
Memarian, A1
Sedighi, S1
Behnampour, N1
Yan, XJ1
Qi, M1
Telusma, G1
Yancopoulos, S1
Madaio, M1
Satoh, M1
Reeves, WH1
Teichberg, S1
Kohn, N1
Auborn, K1
Chiorazzi, N1
McAlindon, TE1
Gulin, J1
Chen, T1
Klug, T1
Lahita, R1
Nuite, M1

Trials

1 trial available for indole-3-carbinol and Libman-Sacks Disease

ArticleYear
Indole-3-carbinol in women with SLE: effect on estrogen metabolism and disease activity.
    Lupus, 2001, Volume: 10, Issue:11

    Topics: Adult; Estrogen Antagonists; Estrogens; Female; Humans; Hydroxyestrones; Indoles; Lupus Erythematosu

2001

Other Studies

3 other studies available for indole-3-carbinol and Libman-Sacks Disease

ArticleYear
Effect of indole-3-carbinol on transcriptional profiling of wound-healing genes in macrophages of systemic lupus erythematosus patients: an RNA sequencing assay.
    Lupus, 2020, Volume: 29, Issue:8

    Topics: Adult; Case-Control Studies; Cyclin-Dependent Kinase Inhibitor p21; Female; Fibronectins; Gene Expre

2020
Immunoregulatory effects of indole-3-carbinol on monocyte-derived macrophages in systemic lupus erythematosus: A crucial role for aryl hydrocarbon receptor.
    Autoimmunity, 2018, Volume: 51, Issue:5

    Topics: Basic Helix-Loop-Helix Transcription Factors; Case-Control Studies; Cells, Cultured; Cytokines; Fema

2018
Indole-3-carbinol improves survival in lupus-prone mice by inducing tandem B- and T-cell differentiation blockades.
    Clinical immunology (Orlando, Fla.), 2009, Volume: 131, Issue:3

    Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Autoantibodies; B-Lymphocytes; Cell Differen

2009